Atlas Trials

Efficacy and Safety of Empagliflozin in GSD-Ib Patients

Clinical trial NCT05960617 · WITHDRAWN

Trial details

NCT number
NCT05960617
Sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Glycogen Storage Disease Type IB
Start date
2023-07-15
Primary completion
2024-06-30
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.